Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up

Table 5 Predictors for new-onset diabetes

Risk factor	Univariate analysis
	HR	95% CI		p-value
	HR	Lower	Upper	p-value
Pitavastatin 4 mg	0.63	0.27	1.48	0.29
Number of metabolic syndrome components
1	–
2	0.92	0.30	2.83	0.89
3	0.82	0.24	2.75	0.74
4	1.05	0.24	4.55	0.95
Age	0.99	0.65	1.03	0.63
Female	0.91	0.35	2.35	0.84
Body mass index	1.01	0.88	1.16	0.91
Hypertension	0.82	0.35	1.89	0.64
Total cholesterol	1.01	0.99	1.01	0.86
Triglyceride	1.00	0.99	1.01	0.82
HDL-cholesterol	0.96	0.92	1.01	0.11
LDL-cholesterol	1.00	0.99	1.02	0.58
hsCRP	1.01	0.99	1.04	0.23
Fasting glucose	1.01	0.99	1.02	0.15
HbA1c	6.61	0.69	63.18	0.10

HbA_1c hemoglobin A_1c, HDL high-density lipoprotein, hsCRP high sensitivity C-reactive protein, LDL low-density lipoprotein

ISSN: 1475-2840